01789.HK
AK Medical Holdings Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 4.56
+1.56%Year over year
Reported trailing growth
- Revenue
- +12.2%
- EBITDA
- +27.3%
- EBIT
- +35.3%
- EPS
- +30.8%
- Free cash flow
- -21.5%
- Operating cash flow
- -28.9%
Forward estimates
Based on analyst estimates
- Revenue
- -42.2%
- EBITDA
- -41.1%
- EPS
- -43.1%
Three-year CAGR
- Revenue
- +12.1%
- EBITDA
- +14.2%
- EBIT
- +19.3%
- Net income
- +18.3%
- EPS
- +18.6%
- Free cash flow
- +37.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026